Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Sensory and Motor Systems

The Antiarrhythmic Drug Flecainide Enhances Aversion to HCl in Mice

Yuko Kawabata, Shingo Takai, Keisuke Sanematsu, Ryusuke Yoshida, Fuminori Kawabata and Noriatsu Shigemura
eNeuro 11 September 2023, 10 (9) ENEURO.0048-23.2023; DOI: https://doi.org/10.1523/ENEURO.0048-23.2023
Yuko Kawabata
1Section of Oral Neuroscience, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shingo Takai
1Section of Oral Neuroscience, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keisuke Sanematsu
1Section of Oral Neuroscience, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
2Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka 819-0395, Japan
5Oral Health/Brain Health/Total Health Research Center, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryusuke Yoshida
3Department of Oral Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fuminori Kawabata
4Physiology of Domestic Animals, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki 036-8561, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriatsu Shigemura
1Section of Oral Neuroscience, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
2Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka 819-0395, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noriatsu Shigemura
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Drug-induced taste disorders reduce quality of life, but little is known about the molecular mechanisms by which drugs induce taste disturbances. In this study, we investigated the short-term and long-term effects of the antiarrhythmic drug flecainide, which is known to cause taste dysfunction. Analyses of behavioral responses (licking tests) revealed that mice given a single intraperitoneal injection of flecainide exhibited a significant reduction in preference for a sour tastant (HCl) but not for other taste solutions (NaCl, quinine, sucrose, KCl and monopotassium glutamate) when compared with controls. Mice administered a single dose of flecainide also had significantly higher taste nerve responses to HCl but not to other taste solutions. Compared with controls, mice administered flecainide once-daily for 30 d showed a reduced preference for HCl without any changes in the behavioral responses to other taste solutions. The electrophysiological experiments using HEK293T cells transiently expressing otopetrin-1 (Otop1; the mouse sour taste receptor) showed that flecainide did not alter the responses to HCl. Taken together, our results suggest that flecainide specifically enhances the response to HCl in mice during short-term and long-term administration. Although further studies will be needed to elucidate the molecular mechanisms, these findings provide new insights into the pathophysiology of drug-induced taste disorders.

  • antiarrhythmic drug
  • flecainide
  • taste
  • taste disorder

Significance Statement

Drug-induced taste disorders reduce quality of life and can lead to nutritional disturbances. However, little is known about its molecular mechanisms. We focused on the antiarrhythmic drug flecainide inducing “unpleasant or bad taste” in human patients. Mice administered a single dose of flecainide exhibited a reduced preference for and higher taste nerve responses to HCl, sour tastants specifically. Flecainide had little change in response to HCl in HEK293T cells expressing the sour taste receptor, proton channel otopetrin-1 (Otop1). Our results suggest that flecainide enhances the responses of sour-sensing taste cells to HCl. Although further studies will be needed to elucidate the molecular mechanisms, these findings provide new insights into the pathophysiology of drug-induced taste disorders.

Introduction

More than 280 different medications are known to cause alterations in taste perception in patients, and these adverse reactions are known as drug-induced taste disorders (Naik et al., 2010). Such drug-induced taste disorders reduce quality of life and can lead to nutritional disturbances, malnutrition, and poor adherence to management plans. However, little is known about the molecular mechanisms that underlie drug-induced taste disorders.

Flecainide is an antiarrhythmic drug known to cause taste dysfunction. Flecainide, a widely used antiarrhythmic drug, prevents supraventricular and ventricular arrhythmias, paroxysmal atrial fibrillation and flutter (Mueller and Baur, 1986). The main antiarrhythmic action of this drug is thought to be because of the inhibition of voltage-gated sodium channels (SCN5A), which slows the conduction of electrical impulses within the heart and prolongs the refractory period of ventricular and atrial myocytes (H. Liu et al., 2002). Flecainide also inhibits cardiac potassium channels (KCNB1) contributing to the delayed rectifier potassium current (Tamargo et al., 2004), which also increases cardiac refractoriness. Additionally, flecainide was reported to block calcium release channel, ryanodine receptor-2 (RyR2), and thereby suppress calcium waves in cardiomyocytes and prevent catecholaminergic polymorphic ventricular tachycardia in mice and humans (Watanabe et al., 2009). A study examining the long-term efficacy of flecainide in the treatment of supraventricular tachycardia found that some patients experienced central nervous system side effects such as visual disturbances (∼20% of cases), nervousness (4%), dizziness (2.4%), and taste disturbances (5%; Neuss, 1985). Furthermore, some patients describe “unpleasant or bad taste” as an adverse reaction of flecainide (Muhiddin et al., 1985; Kreeger and Hammill, 1987). However, the molecular mechanisms underlining the unwanted effects of flecainide on the taste system have not been elucidated.

Taste buds consist of 50–100 taste cells that interact with gustatory nerves. Recent molecular studies have discovered candidate receptors for five basic tastes (Lindemann, 2001; Chandrashekar et al., 2006; Shigemura and Ninomiya, 2016). These receptors are divided into two types: G-protein-coupled receptors (GPCRs) that discriminate sweet, bitter and umami tastes, and channel-type receptors that discriminate salty and sour tastes. The taste receptors for sweet [taste receptor type 1 member 2 (T1R2) and T1R3], bitter [taste receptor type 2 (T2R)], salty [epithelial sodium channel (ENaC)] and sour [otopetrin-1 (Otop1); Tu et al., 2018] are expressed in a distinct subset of cells in taste buds, which suggests that the coding of taste quality may occur at the level of taste cells. Taste cells expressing GPCRs for sweet, bitter or umami use multiple ion channels such as TRP channel subfamily M member 5 (TRPM5), voltage-gated sodium channels (SCN2A, SCN3A, SCN9A) and voltage-gated potassium channels (KCNQ1) in the transduction cascades (Ohmoto et al., 2006; Wang et al., 2009). The other taste cells expressing Otop1, use voltage-gated calcium channels (alpha1A) in addition to SCN2A, and potassium channels (KCNQ1, Kir2.1; Medler et al., 2003; L. Liu et al., 2005; DeFazio et al., 2006; Gao et al., 2009; Ye et al., 2016). Furthermore, L-type voltage-gated calcium channels are thought to interact with RyRs in mouse taste cells (Rebello et al., 2013). These taste type-specific ion channels play important roles in the regulation of distinct taste cell excitability.

We thus explored the pathomechanisms of the adverse reactions of flecainide on the taste system. We investigated the effects of flecainide on the behavioral and neural responses of mice to taste stimuli, the whole cell current of HEK293T cells transiently expressing mouse Otop1. We found that flecainide specifically enhances the sour taste substance HCl responses in mice. The results in Otop1-expressing cells provided no suggestion that flecainide may be involved in a pathway of sour-sensing proton channel, Otop1. A much more extensive set of experiments is required to demonstrate whether Otop1 is involved. The above actions of flecainide may contribute to the taste disorders experienced by patients as an adverse reaction of this antiarrhythmic drug.

Materials and Methods

Animals

Mouse husbandry and all mouse experiments were conducted in accordance with the ethical guidelines of Kyushu University and the Rules for Animal Experimentation of Hirosaki University. All experimental protocols and procedures were approved by the Committee for Laboratory Animal Care and Use at Kyushu University (approval no. A19-286-0) and the Animal Research Committee of Hirosaki University (approval no. A18002, A19002 and A19009) and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. C57BL/6J mice were purchased from Charles River Laboratories Japan and CLEA Japan. All mice were housed in a 12/12 h light/dark cycle at 23°C and had ad libitum access to water and food pellets (CE-2, CLEA Japan). Male mice aged 8–12 weeks were used for all experiments (Takai et al., 2015).

Taste compounds and drugs

The following taste solutions were used in this study: acetic acid (AA), citric acid (CA), HCl, NaCl (with or without amiloride), KCl, sucrose [with quinine-HCl (QHCl)], QHCl, NH4Cl (all purchased from Fujifilm Wako Pure Chemical Corporation) and monopotassium glutamate (MPG; Sigma-Aldrich). All taste solutions were dissolved in distilled water (DW; Yoshida et al., 2010). The following antiarrhythmic drugs were used: amiodarone (A2530, Tokyo Chemical Industry), flecainide (F6777, Sigma-Aldrich) and propafenone (P2301, Tokyo Chemical Industry). All drugs were dissolved in dimethyl sulfoxide (Fujifilm Wako Pure Chemical Corporation). For the behavioral and neural experiments, a stock solution of flecainide was diluted in vehicle (5% glucose) to its final concentration just before administration by intraperitoneal injection. The dose of flecainide administered was determined with reference to the dose for humans stated in the prescribing information.

Short-term lick test

Details of the procedures used for this test are described in our previous papers (Yoshida et al., 2010; Shigemura et al., 2013; Takai et al., 2015). Each animal was deprived of water for 23 h, placed in the test cage on day 1 of training and then given free access to DW during a 1-h session. During training sessions on days 2–5, the animal was trained to drink DW on an interval schedule that consisted of 10-s periods of presentation of DW alternated with 20-s inter-trial intervals. On day 6, the number of licks for each test stimulus and DW was counted during the first 10 s after the animal’s first lick using a lick meter (Yutaka Electronics). Measurements of the number of licks 30 min after the intraperitoneal injection of drug were made in the following four experimental groups: (1) a single injection of vehicle (5% glucose); (2) a single injection of flecainide (2 mg/kg body weight, equivalent to the maximal daily dose in humans) dissolved in vehicle (Watanabe et al., 2009); (3) repeated administrations of vehicle for 30 d; and (4) repeated administrations of flecainide (2 mg/kg body weight) for 30 d. The measurements were made the day after last administration in the repeated administration groups. On each test day, the first test stimulus given to the animal was DW, and then the following solutions were tested in a randomized order: 1–50 mm AA, 1–30 mm CA, 1–30 mm HCl, 30–1000 mm NaCl (with and without 30 μm amiloride), 10–300 mm KCl, 30–1000 mm sucrose (with 0.1 mm QHCl), 0.003–3 mm QHCl and 1–1000 mm MPG. The mean value of the tastant/DW lick ratio for each test stimulus was calculated for each animal.

Recording of CT nerve responses

Whole nerve responses to lingual application of tastants were recorded from the CT nerve as described previously (Yoshida et al., 2010; Shigemura et al., 2013; Takai et al., 2015). The trachea of each mouse was canulated under pentobarbital anesthesia (50–60 mg/kg body weight), and the mouse was then fixed in the supine position with a head holder to allow dissection of the CT nerve. The right CT nerve was dissected free from surrounding tissues after removal of the pterygoid muscle and cut at the point of its entry to the bulla. The entire nerve was placed on an Ag/AgCl electrode. An indifferent electrode was placed in nearby tissue. Neural activity was fed into an amplifier (K-1; Iyodenshikagaku) and monitored on an oscilloscope and audio monitor. Whole nerve responses were integrated with a time constant of 1.0 s and recorded on a computer using a PowerLab/sp4 system (ADInstruments). For taste stimulation of the fungiform papillae, the anterior half of the tongue was enclosed in a flow chamber made of silicone rubber. Taste solutions (100 mm NH4Cl, 3–50 mm AA, 1–30 mm CA, 1–30 mm HCl, 30–1000 mm NaCl, 100 mm KCl, 30–1000 mm sucrose, 20 mm QHCl and 100 mm MPG) were delivered to each part of the tongue by gravity flow for 30 s. The tongue was washed with DW for ∼1 min between successive stimulations. After a series of control responses had been recorded, each mouse received a single intraperitoneal injection of flecainide (2 mg/kg body weight) dissolved in vehicle (5% glucose). Another series of responses was recorded 15–30 min after flecainide administration, in accordance with a previous study (Watanabe et al., 2009). Only data from stable recordings were used for the analysis. The magnitude of the integrated whole nerve response was measured during 30-s stimulation. The response was averaged over a 20-s period after excluding the data for the initial and final 5-s periods, and this value was normalized to the response to 100 mm NH4Cl to account for interanimal variations in the absolute responses. Because the cell type involved in the NH4Cl response may be Type III cells (Oka et al., 2013), the NH4Cl response was normalized to the baseline, in accordance with a previous study (Vandenbeuch et al, 2013, 2015; Larson et al., 2015, 2020). The baseline-normalized NH4Cl response was not significantly altered by flecainide administration.

Immunohistochemistory

The dissected tongues of each animal (n = 3) were fixed in 4% paraformaldehyde (PFA) in PBS for 50 min. After dehydration with sucrose solution (10% for 1 h, 20% for 1 h, 30% for 3 h at 4°C), the frozen block of fixed tissue was embedded in optimal cutting temperature (OCT) compound (Sakura Finetek) and sectioned into 10-μm-thick slices, which were mounted on silane-coated glass slides. Next, sections of the tongue incubated for 1 h in Blocking One solution (Nacalai Tesque) and then incubated overnight at 4°C with the primary antibody against PLCβ2 (1:200; rabbit anti-PLCβ2, Santa Cruz Biotechnology) or CA4 (1:100; goat anti-CA4, R&D Systems). After washing with TNT buffer, the slides were incubated for 2 h with secondary antibody: Alexa Fluor 568 donkey anti-rabbit IgG (Invitrogen) for PLCβ2, and Alexa Fluor 488 donkey anti-goat IgG (Invitrogen) for CA4.

Immunofluorescence of labeled taste cells was observed using a laser scanning microscope (FV-1000, Olympus); images were obtained using Fluoview software (Olympus). To determine the number of cells expressing PLCβ2 and CA4, we counted positive cells in each taste bud in horizontal sections of the circumvallate papillae. Image-ProPlus (version 4.0; Mediacybernetics) was used to exclude artifactual signals; the cells showing a signal density greater than the mean plus two standard deviations of the density in taste cells in the negative control (primary antibodies omitted) were considered positive.

Construction of mouse Otop1

Total RNA was isolated from mouse kidney, and first-strand cDNA was synthesized using the SuperScript IV First-strand Synthesis System (Thermo Fisher Scientific). The deduced open reading frames (ORFs) of mouse Otop1 (mOtop1) were amplified in two steps by nested-PCR using PrimeSTAR MAX (TaKaRa Bio). Exon-spanning primers were designed based on the mOtop1 nucleotide sequence in the NCBI database (accession no. NM_172709.3). The PCR products of the ORFs were subcloned into the pcDNA5/FRT mammalian expression vector using the In-Fusion HD Cloning kit (Takara Bio). The entire sequence of mOtop1 was confirmed using a BigDye Terminator system (Applied Biosystems).

Electrophysiology

Whole-cell patch-clamp recordings were performed as described previously (Liang et al., 2019). mOtop1/pcDNA5/FRT/TO was co-transfected with EGFP/pCAGGS into HEK293T cells using ScreenFect A. The standard and acidic bath solutions contained 140 mm NaCl, 5 mm KCl, 10 mm HEPES, 2 mm MgCl2, 2 mm CaCl2, and 10 mm glucose. The acidic bath solutions contained 5 mm HCl with 15 μm flecainide or DMSO (dimethyl sulfoxide; the vehicle of flecainide). As the human ASIC1a channel in HEK293T cells can be blocked by a pH 6.8 bath solution (Gunthorpe et al., 2001), we adjusted the standard bath solution to pH 6.8 with NaOH. Cells were voltage-clamped at −60 mV using an EPC10 amplifier (HEKA Elektronik). Patch pipettes had resistances between 2 and 5 MΩ, and they were filled with a pipette solution consisting of 140 mm KCl, 5 mm EGTA, and 10 mm HEPES. We adjusted the pipette solution to pH 7.4 with KOH. 5 mm HCl + DMSO in bath solution was pH 3.22 and 5 mm HCl + 15 μm flecainide in bath solution was pH 3.21. There was no difference between the two solutions.

Statistical analysis

Data are shown as mean ± SD. The short-term lick scores and the CT nerve responses were compared by unpaired t test with Bonferroni correction as post hoc test preceded by factorial two-way ANOVA. The electrophysiology and the immunohistochemistry were compared by unpaired t test. IBM SPSS Statistics (IBM Corp.) was used to perform all calculations.

Results

Short-term effects of flecainide on the behavioral responses of mice to taste stimuli

First, we investigated the effects of a single dose of flecainide on the licking behavior of mice in response to taste stimuli. The lick ratio for HCl was significantly lower in mice treated with flecainide than in control mice (F(1,60) = 41.383, p < 0.001, ANOVA, effect of flecainide; Fig. 1A; Table 1). By contrast, the lick ratios for other taste solutions including weak acids (AA and CA), NaCl, NaCl plus amiloride, KCl, QHCl, sucrose plus QHCl, and MPG were not significantly altered by flecainide (p > 0.05, ANOVA, Fig. 1B–I; Table 1).

View this table:
  • View inline
  • View popup
Table 1

Results of statistical analysis for the effect of injection of Fle on the lick ratio (Fig. 1)

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Short-term administration of flecainide enhances the behavioral responses of mice to HCl. Concentration-response relationships for varying concentrations of HCl (A), acetic acid (AA; B), citric acid (CA; C), NaCl (D), NaCl + 30 μm amiloride (E), KCl (F), sucrose + 0.1 mm quinine-HCl (QHCl; G), QHCl (H) and monopotassium glutamate (MPG; I) 30 min after intraperitoneal injection of vehicle (white symbols) or 2 mg/kg body weight flecainide (Fle, blue symbols). The lick ratio to distilled water is presented as the mean ± SD (n = 5–8). ***p < 0.001 (two-way ANOVA), ††p < 0.002, †††p < 0.0002 (unpaired t test with Bonferroni correction).

Short-term effects of flecainide on the gustatory nerve responses to taste stimuli in mice

Next, we investigated the effects of a single dose of flecainide on the gustatory nerve responses to various taste stimuli in mice. We focused on the response of the chorda tympani (CT) nerve, which innervates the anterior part of the tongue responsible for sour taste discrimination (Teng et al., 2019; Zhang et al., 2019). The CT nerve response to HCl was significantly greater in flecainide-treated mice than in control mice, and there was a significant difference by post hoc test only at 5 mm HCl but not at the other concentrations tested; that is, there was an overall effect of injection, and the strongest difference was at 5 mm [p < 0.01, t test (Fig. 2B,C), and F(1,51) = 5.658, p = 0.021, ANOVA, effect of flecainide (Fig. 2C); Table 2]. What is more, the increased responses to 5 mm HCl after flecainide appeared because of a prolongation of the response, rather than an increase in peak. By contrast, flecainide was without significant effect on the CT nerve responses to other taste solutions such as AA, CA, NaCl, KCl, sucrose, QHCl, and MPG (p > 0.05, t test or ANOVA; Fig. 2A,B,D–G; Table 2). Furthermore, flecainide had little effect on the NH4Cl responses (p = 0.35, t test; Fig. 2H).

View this table:
  • View inline
  • View popup
Table 2

Results of statistical analysis for the effect of injection of Fle on the CT nerve response in mice (Fig. 2)

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Flecainide enhances corda tympani (CT) nerve responses to HCl in mice. A, Representative examples of CT nerve responses to various taste solutions obtained after the intraperitoneal injection of vehicle (Ctrl, upper traces) or 2 mg/kg body weight flecainide (Fle, lower traces). B, CT nerve responses (normalized to that for 100 mm NH4Cl) to sour [5 mm HCl; 30 mm acetic acid (AA); 10 mm citric acid (CA)], salty (100 mm NaCl; 100 mm KCl), sweet [300 mm sucrose (Suc)], bitter [20 mm quinine-HCl (QHCl)] and umami [100 mm monopotassium glutamate (MPG)] compounds recorded 15–30 min after the administration of vehicle (Ctrl, gray bars) or 2 mg/kg body weight flecainide (Fle, blue bars). Data are presented as the mean ± SD (n = 6–11). **p < 0.01 (unpaired t test). (C–G) Concentration-dependent responses to HCl (C) AA (D), CA (E), NaCl (F), and sucrose (G) obtained 15–30 min after the administration of vehicle (Ctrl, white symbols) or 2 mg/kg body weight flecainide (Fle, blue symbols). Data are presented as the mean ± SD (n = 4–11). *p < 0.05 (two-way ANOVA), †p < 0.01 (unpaired t test with Bonferroni correction). H, CT nerve responses (normalized to that for distilled water) to 100 mm NH4Cl recorded 15–30 min after the administration of vehicle (Ctrl, gray bar) or 2 mg/kg body weight flecainide (Fle, blue bar). Data are presented as the mean ± SD (n = 11). p = 0.35 (unpaired t test), n.s. = no significance.

Long-term effects of flecainide on the behavioral responses of mice to taste stimuli

We evaluated the long-term effects of flecainide on the behavioral responses to taste stimuli in mice given repeated intraperitoneal injections of flecainide for 30 d. The lick ratio for HCl was significantly lower in flecainide-treated mice than in control mice (F(1,40) = 9.977, p = 0.003, ANOVA, effect of flecainide; Fig. 3A; Table 3), whereas the lick ratios for other taste solutions (such as NaCl, NaCl plus amiloride, KCl, sucrose plus QHCl, QHCl, MPG, AA, and CA) were not affected by flecainide (p > 0.05, ANOVA; Fig. 3B–I; Table 3). No change in the number of Type II and Type III taste cells was observed after 30 d of treatment with flecainide (Fig. 4A,B; Table 4).

View this table:
  • View inline
  • View popup
Table 3

Results of statistical analysis for the effect of injection of Fle on the lick ratio in mice (Fig. 3)

View this table:
  • View inline
  • View popup
Table 4

Results of statistical analysis for the effect of Fle on mouse taste bud cells (Fig. 4)

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Long-term administration of flecainide enhances the behavioral responses of mice to HCl. Concentration-response relationships for varying concentrations of HCl (A), acetic acid (AA; B), and citric acid (CA; C), NaCl (D), NaCl + 30 μm amiloride (E), KCl (F), sucrose + 0.1 mm quinine-HCl (QHCl; G), QHCl (H) and monopotassium glutamate (MPG; I) obtained after daily intraperitoneal injections of vehicle (Ctrl, white symbols) or 2 mg/kg body weight flecainide (Fle, blue symbols) for 30 d. The lick ratio to distilled water is presented as the mean ± SD (n = 5). **p < 0.01 (two-way ANOVA).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Effects of flecainide on mouse taste bud cells. A, Expression of phospholipase C-β 2 (PLCβ2, a bitter/sweet/umami transduction molecule; magenta), and carbonic anhydrase-4 (CA4, a sour taste sensitive cell marker; green) in the circumvallate papillae after daily intraperitoneal injections of vehicle (Ctrl) or 2 mg/kg body weight flecainide (Fle) for 30 d. Scale bar: 50 μm. B, Quantitation of the number of immunoreactive taste cells per taste bud. Data are expressed as the mean ± SD; n = 60–83 taste buds, each (n = 3 mice). n.s. = no significance.

Effects of flecainide on the responses of HEK293T cells expressing Otop1

Our subsequent experiments explored whether the Otop1 channel, a sour taste receptor (Tu et al., 2018; Teng et al., 2019; Zhang et al., 2019), might be involved in the effects of flecainide on the behavioral and neural responses to HCl. We used a mOtop1/pcDNA5 construct (Table 5) to generate HEK293T cells transiently expressing mOtop1 protein and analyzed the effects of flecainide on Otop1-expressing cells using whole-cell patch clamp test. The representative currents of Otop1 by 5 mm HCl with DMSO (the vehicle of flecainide) or 5 mm HCl with 15 μm flecainide were shown in Figure 5A,B, respectively. Although the peak current densities were not different between two stimuli (Fig. 5C; Table 6). These results of the present simplified experiments suggest that flecainide does not directly affect the channel activities of Otop1, although the involvement of Otop1 needs to be discussed based on further extensive experiments.

View this table:
  • View inline
  • View popup
Table 5

Primers for construction of mOtop1

View this table:
  • View inline
  • View popup
Table 6

Results of statistical analysis for the effect of application of Fle on the electrophysiology of mOtop1-expressing HEK293T cells (Fig. 5)

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

The typical currents of Otop1 by 5 mm HCl with DMSO (the vehicle of flecainide; A) or 5 mm HCl with 15 μm flecainide (B) are shown in whole-cell patch clamp tests at −60 mV. C, The comparison of peak current densities of Otop1 between the stimuli of the 5 mm HCl with DMSO and 5 mm HCl with 15 μm flecainide (mean ± SD, n = 6 cells). n.s. = no significance.

Discussion

The aim of this study was to provide insights into the pathomechanisms underlying flecainide-induced taste disorders. Flecainide is known to cause taste dysfunction as an adverse reaction (Muhiddin et al., 1985; Kreeger and Hammill, 1987), but little is elucidated about the symptoms, and mechanisms. Our in vivo experiments were the first to characterize that the administration of flecainide exhibited a reduced preference for and higher taste nerve responses to HCl, sour tastant specifically. However, in the experiments with HEK293T cells expressing mOtop1, we could not observe the effects of flecainide on the response to HCl in HEK293T cells. This discrepancy may be because of the possibility that the enhancement effect of flecainide on HCl is mediated by other sour sensory signals rather than Otop1 in sour taste cells.

Multiple sour taste receptor candidates have been proposed such as acid-sensing ion channels (ASICs; Ugawa et al., 2003), hyperpolarization-activated cyclic nucleotide-gated potassium channels (HCNs; Stevens et al., 2001), potassium channels (Lin et al., 2004; Richter et al., 2004), polycystic kidney disease 2L1 (PKD2L1) and PKD1L3 heteromers (Huang et al., 2006; Ishimaru et al., 2006; Lopezjimenez et al., 2006), and Otop1 (Tu et al., 2018). Recently, it was reported that knock-out of Otop1 abolished sour taste responses from mouse sour-sensing taste receptor cells (Teng et al., 2019). The mice engineered to express Otop1 in sweet taste receptor cells possessed taste cells that responded to both sweet and sour stimuli (Zhang et al., 2019). These findings indicated that Otop1 plays a central role in the perception of sour taste in mice. Flecainide acts as a blocker for several voltage-gated K+ channels (Kv), such as hERG (Kv11.1, encoded by KCNH2) at clinically relevant concentrations in whole cell voltage clamp recordings of hERG current made from an HEK293 cell line stably expressing hERG (Paul et al., 2002). The previous histologic and transcriptome analyses showed hERG is expressed in sour taste cells (Ohmoto et al., 2006; Ren et al., 2017), thus blockade of hERG by flecainide could increase the excitability of sour cells. In the cardiac inwardly rectifying current, IK1, mainly Kir2.1 (KCNJ2, encoded in inwardly rectifying potassium channels), flecainide also has a putative differential effect of blocking atrial IK1 and increasing ventricular IK1 (Caballero et al., 2010). These differences depend on the variations in expression profiles of the other IK1 components, Kir2.2 and Kir2.3, between animal species or tissues (Caballero et al., 2010). Kir2.1 is a key component of sour taste transduction by generating response in sour-responsive cells by blocking resting K+ currents because of intracellular acidification (Ye et al., 2016). It is possible that flecainide also blocks Kir2.1 in sour cells, resulting in increased cell excitation.

The somatosensory inputs via trigeminal nerve are supposed to be one of the components of the remaining acid responses in Otop1-KO mice (Teng et al., 2019). Proton stimulates TRPV1, a capsaicin, protons, and heat-sensitive nonselective cation channel, in trigeminal neurons (L. Liu and Simon, 2000). According to the previous papers, TRPV1 function (potentiation of capsaicin responses and development of thermal hypersensitivity) was attenuated in P2Y2-KO mice (Malin et al., 2008), and P2Y2-induced hyperalgesia is not observed in TRPV1-KO animals, indicating a functional interaction between TRPV1 and P2Y2 (Moriyama et al., 2003). The activation of P2Y2 downregulate Kv4.2 expression, encoded by KCND2, a voltage-gated potassium channel which expressed in trigeminal neurons, results in the reduced current density and the enhanced neuronal excitability in rat trigeminal neurons (Li et al., 2014). Flecainide is reported as a blocker for Kv4.2 in somatosensory neurons (Caballero et al., 2003), thus, an application of flecainide may inhibit Kv4.2 in trigeminal neurons expressing both TRPV1 and P2Y2, and enhance acid sensation via TRPV1. This enhanced sensation in somatosensory neurons may be involved in the increased behavioral aversion to HCl in flecainide-treated animals, in concert with the activation of sour taste cells. In addition, the potentiation of proton sensing may be a possible explanation why changes were observed only in low pH strong acid (HCl) but not for weak acids (AA and CA) in our electrophysiological and behavioral experiments (Table 7).

View this table:
  • View inline
  • View popup
Table 7.

The pH value of each acid in the short-term lick test (Figs. 1 and 3)

Various modulators of sour taste have been reported previously. For example, noradrenaline was found to significantly reduce the sour taste threshold by 22% and the bitter taste threshold by 39% in healthy humans (Heath et al., 2006). Mice lacking the receptor for ghrelin, an orexigenic hormone, showed reduced behavioral responses to sour and salty tasting compounds (Shin et al., 2010). Furthermore, mice lacking the receptor for glucagon-like peptide-1, an incretin hormone that stimulates insulin secretion, exhibited reduced sweet taste sensitivity and enhanced citric acid taste sensitivity in behavioral assays (Shin et al., 2008). Thus, although multiple factors have been found to modulate sour taste sensitivity in humans and mice, they were not specific for the sour taste modality. This may be because of nonspecific expression of their cognate receptors in the taste buds. In the present study, flecainide specifically enhanced sour taste without any effects on the other basic taste responses. This is the first finding that sour taste sensitivity is enhanced selectively by the application of a specified substance.

In summary, we report the taste alteration that occurs as an adverse reaction of flecainide, a widely used arrhythmic drug. Our experiments revealed that flecainide specifically enhances the response to HCl, sour tastant in mice during short-term and long-term administration without causing histologic changes. Although further studies will be needed to elucidate the molecular mechanisms, our findings contribute new insights into the understanding of the pathophysiology on drug-induced taste disorders.

Acknowledgments

Acknowledgements: We thank Dr. Shusuke Iwata, Dr. Fumie Hirose, and Dr. Ayana Osaki for their technical assistance with CT nerve recordings; Mayuko Inoue for technical assistance with immunohistochemistry; and Akari Yamada for technical assistance with whole-cell patch clamp. We thank OxMedComms for proofreading this manuscript.

Footnotes

  • The authors declare no competing financial interests.

  • This work was supported by JSPS KAKENHI Grants JP19H03818, JP18J20599, JP19KT0005, JP22K19672, and JP23K15979.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Caballero R, Pourrier M, Schram G, Delpón E, Tamargo J, Nattel S (2003) Effects of Flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines. Br J Pharmacol 138:1475–1484. https://doi.org/10.1038/sj.bjp.0705199 pmid:12721103
    OpenUrlCrossRefPubMed
  2. ↵
    Caballero R, Dolz-Gaitón P, Gómez R, Amorós I, Barana A, Fuente MG, Osuna L, Duarte J, López-Izquierdo A, Moraleda I, Gálvez E, Sánchez-Chapula JA, Tamargo J, Delpón E (2010) Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification. Proc Natl Acad Sci U S A 107:15631–15636. https://doi.org/10.1073/pnas.1004021107 pmid:20713726
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Chandrashekar J, Hoon MA, Ryba NJP, Zuker CS (2006) The receptors and cells for mammalian taste. Nature 444:288–294. https://doi.org/10.1038/nature05401 pmid:17108952
    OpenUrlCrossRefPubMed
  4. ↵
    DeFazio RA, Dvoryanchikov G, Maruyama Y, Kim JW, Pereira E, Roper SD, Chaudhari N (2006) Separate populations of receptor cells and presynaptic cells in mouse taste buds. J Neurosci 26:3971–3980. https://doi.org/10.1523/JNEUROSCI.0515-06.2006 pmid:16611813
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Gao N, Lu M, Echeverri F, Laita B, Kalabat D, Williams ME, Hevezi P, Zlotnik A, Moyer BD (2009) Voltage-gated sodium channels in taste bud cells. BMC Neurosci 10:20. https://doi.org/10.1186/1471-2202-10-20 pmid:19284629
    OpenUrlCrossRefPubMed
  6. ↵
    Gunthorpe M, Smith G, Davis J, Randall A (2001) Characterisation of a human acid-sensing ion channel (hASIC1a) endogenously expressed in HEK293 cells. Pflugers Arch 442:668–674. pmid:11512022
    OpenUrlCrossRefPubMed
  7. ↵
    Heath TP, Melichar JK, Nutt DJ, Donaldson LF (2006) Human taste thresholds are modulated by serotonin and noradrenaline. J Neurosci 26:12664–12671. https://doi.org/10.1523/JNEUROSCI.3459-06.2006 pmid:17151269
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Huang AL, Chen X, Hoon MA, Chandrashekar J, Guo W, Tränkner D, Ryba NJP, Zuker CS (2006) The cells and logic for mammalian sour taste detection. Nature 442:934–938. https://doi.org/10.1038/nature05084 pmid:16929298
    OpenUrlCrossRefPubMed
  9. ↵
    Ishimaru Y, Inada H, Kubota M, Zhuang H, Tominaga M, Matsunami H (2006) Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc Natl Acad Sci U S A 103:12569–12574. https://doi.org/10.1073/pnas.0602702103 pmid:16891422
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Kreeger RW, Hammill SC (1987) New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone. Mayo Clin Proc 62:1033–1050. https://doi.org/10.1016/s0025-6196(12)65077-0 pmid:3118116
    OpenUrlPubMed
  11. ↵
    Larson ED, Vandenbeuch A, Voigt A, Meyerhof W, Kinnamon SC, Finger TE (2015) The role of 5-HT3 receptors in signaling from taste buds to nerves. J Neurosci 35:15984–15995. https://doi.org/10.1523/JNEUROSCI.1868-15.2015 pmid:26631478
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Larson ED, Vandenbeuch A, Anderson CB, Kinnamon SC (2020) Function, innervation, and neurotransmitter signaling in mice lacking type-II taste cells. eNeuro 7:ENEURO.0339-19.2020. https://doi.org/10.1523/ENEURO.0339-19.2020
    OpenUrl
  13. ↵
    Li N, Lu Z, Yu L, Burnstock G, Deng X, Ma B (2014) Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain. Mol Pain 10:21. https://doi.org/10.1186/1744-8069-10-21 pmid:24642246
    OpenUrlCrossRefPubMed
  14. ↵
    Liang R, Kawabata Y, Kawabata F, Nishimura S, Tabata S (2019) Differences in the acidic sensitivity of transient receptor potential vanilloid 1 (TRPV1) between chickens and mice. Biochem Biophys Res Commun 515:386–393. https://doi.org/10.1016/j.bbrc.2019.05.129 pmid:31155288
    OpenUrlPubMed
  15. ↵
    Lin W, Burks CA, Hansen DR, Kinnamon SC, Gilbertson TA (2004) Taste receptor cells express pH-sensitive leak K+ channels. J Neurophysiol 92:2909–2919. https://doi.org/10.1152/jn.01198.2003 pmid:15240769
    OpenUrlCrossRefPubMed
  16. ↵
    Lindemann B (2001) Receptors and transduction in taste. Nature 413:219–225. https://doi.org/10.1038/35093032 pmid:11557991
    OpenUrlCrossRefPubMed
  17. ↵
    Liu H, Tateyama M, Clancy CE, Abriel H, Kass RS (2002) Channel openings are necessary but not sufficient for use-dependent block of cardiac Na+ channels by flecainide: evidence from the analysis of disease-linked mutations. J Gen Physiol 120:39–51. https://doi.org/10.1085/jgp.20028558 pmid:12084774
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Liu L, Simon SA (2000) Capsaicin, acid and heat-evoked currents in rat trigeminal ganglion neurons: relationship to functional VR1 receptors. Physiol Behav 69:363–378. https://doi.org/10.1016/s0031-9384(00)00209-2 pmid:10869604
    OpenUrlCrossRefPubMed
  19. ↵
    Liu L, Hansen DM, Kim I, Gilbertson TA (2005) Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds. Am J Physiol Cell Physiol 289:C868–C880. https://doi.org/10.1152/ajpcell.00115.2005 pmid:15930148
    OpenUrlCrossRefPubMed
  20. ↵
    Lopezjimenez ND, Cavenagh MM, Sainz E, Cruz-Ithier MA, Battey JF, Sullivan SL (2006) Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells. J Neurochem 98:68–77. https://doi.org/10.1111/j.1471-4159.2006.03842.x pmid:16805797
    OpenUrlCrossRefPubMed
  21. ↵
    Malin SA, Davis BM, Koerber RH, Reynolds IJ, Albers KM, Molliver DC (2008) Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2. Pain 138:484–496. https://doi.org/10.1016/j.pain.2008.01.026 pmid:18343036
    OpenUrlCrossRefPubMed
  22. ↵
    Medler KF, Margolskee RF, Kinnamon SC (2003) Electrophysiological characterization of voltage-gated currents in defined taste cell types of mice. J Neurosci 23:2608–2617. https://doi.org/10.1523/JNEUROSCI.23-07-02608.2003 pmid:12684446
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Moriyama T, Iida T, Kobayashi K, Higashi T, Fukuoka T, Tsumura H, Leon C, Suzuki N, Inoue K, Gachet C, Noguchi K, Tominaga M (2003) Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23:6058–6062. https://doi.org/10.1523/JNEUROSCI.23-14-06058.2003 pmid:12853424
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Mueller RA, Baur HR (1986) Flecainide: a new antiarrhythmic drug. Clin Cardiol 9:1–5. https://doi.org/10.1002/clc.4960090102 pmid:3510788
    OpenUrlPubMed
  25. ↵
    Muhiddin KA, Turner P, Hellestrand K, Camm AJ (1985) Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions. Postgrad Med J 61:489–496. https://doi.org/10.1136/pgmj.61.716.489 pmid:2409543
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Naik BS, Shetty N, Maben EVS (2010) Drug-induced taste disorders. Eur J Intern Med 21:240–243. https://doi.org/10.1016/j.ejim.2010.01.017 pmid:20493431
    OpenUrlCrossRefPubMed
  27. ↵
    Neuss H (1985) Long term use of flecainide in patients with supraventricular tachycardia. Drugs 29 [Suppl 4]:21–25. https://doi.org/10.2165/00003495-198500294-00005 pmid:4006776
    OpenUrlPubMed
  28. ↵
    Ohmoto M, Matsumoto I, Misaka T, Abe K (2006) Taste receptor cells express voltage-dependent potassium channels in a cell age-specific manner. Chem Senses 31:739–746. https://doi.org/10.1093/chemse/bjl016 pmid:16873422
    OpenUrlCrossRefPubMed
  29. ↵
    Oka Y, Butnaru M, Von Buchholtz L, Ryba NJP, Zuker CS (2013) High salt recruits aversive taste pathways. Nature 494:472–475. https://doi.org/10.1038/nature11905 pmid:23407495
    OpenUrlCrossRefPubMed
  30. ↵
    Paul AA, Witchel HJ, Hancox JC (2002) Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol 136:717–729. https://doi.org/10.1038/sj.bjp.0704784 pmid:12086981
    OpenUrlCrossRefPubMed
  31. ↵
    Rebello MR, Maliphol AB, Medler KF (2013) Ryanodine receptors selectively interact with L type calcium channels in mouse taste cells. PLoS One 8:e68174. https://doi.org/10.1371/journal.pone.0068174 pmid:23826376
    OpenUrlCrossRefPubMed
  32. ↵
    Ren W, Aihara E, Lei W, Gheewala N, Uchiyama H, Margolskee RF, Iwatsuki K, Jiang P (2017) Transcriptome analyses of taste organoids reveal multiple pathways involved in taste cell generation. Sci Rep 7:4004. https://doi.org/10.1038/s41598-017-04099-5 pmid:28638111
    OpenUrlPubMed
  33. ↵
    Richter TA, Dvoryanchikov GA, Chaudhari N, Roper SD (2004) Acid-sensitive two-pore domain potassium (K2P) channels in mouse taste buds. J Neurophysiol 92:1928–1936. https://doi.org/10.1152/jn.00273.2004 pmid:15140906
    OpenUrlCrossRefPubMed
  34. ↵
    Shigemura N, Ninomiya Y (2016) Recent advances in molecular mechanisms of taste signaling and modifying. Int Rev Cell Mol Biol 323:71–106.
    OpenUrl
  35. ↵
    Shigemura N, Iwata S, Yasumatsu K, Ohkuri T, Horio N, Sanematsu K, Yoshida R, Margolskee RF, Ninomiya Y (2013) Angiotensin II modulates salty and sweet taste sensitivities. J Neurosci 33:6267–6277. https://doi.org/10.1523/JNEUROSCI.5599-12.2013 pmid:23575826
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Shin YK, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang HJ, Mattson MP, Drucker DJ, Egan JM, Munger SD (2008) Modulation of taste sensitivity by GLP-1 signaling. J Neurochem 106:455–463. https://doi.org/10.1111/j.1471-4159.2008.05397.x pmid:18397368
    OpenUrlCrossRefPubMed
  37. ↵
    Shin YK, Martin B, Kim W, White CM, Ji S, Sun Y, Smith RG, Sévigny J, Tschöp MH, Maudsley S, Egan JM (2010) Ghrelin is produced in taste cells and ghrelin receptor null mice show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants. PLoS One 5:e12729. https://doi.org/10.1371/journal.pone.0012729 pmid:20856820
    OpenUrlCrossRefPubMed
  38. ↵
    Stevens DR, Seifert R, Bufe B, Müller F, Kremmer E, Gauss R, Meyerhof W, Kaupp UB, Lindemann B (2001) Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. Nature 413:631–635. https://doi.org/10.1038/35098087 pmid:11675786
    OpenUrlCrossRefPubMed
  39. ↵
    Takai S, Yasumatsu K, Inoue M, Iwata S, Yoshida R, Shigemura N, Yanagawa Y, Drucker DJ, Margolskee RF, Ninomiya Y (2015) Glucagon-like peptide-1 is specifically involved in sweet taste transmission. FASEB J 29:2268–2280. https://doi.org/10.1096/fj.14-265355 pmid:25678625
    OpenUrlCrossRefPubMed
  40. ↵
    Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E (2004) Pharmacology of cardiac potassium channels. Cardiovasc Res 62:9–33. https://doi.org/10.1016/j.cardiores.2003.12.026 pmid:15023549
    OpenUrlCrossRefPubMed
  41. ↵
    Teng B, Wilson CE, Tu YH, Joshi NR, Kinnamon SC, Liman ER (2019) Cellular and neural responses to sour stimuli require the proton channel Otop1. Curr Biol 29:3647–3656.e5. https://doi.org/10.1016/j.cub.2019.08.077 pmid:31543453
    OpenUrlCrossRefPubMed
  42. ↵
    Tu YH, Cooper AJ, Teng B, Chang RB, Artiga DJ, Turner HN, Mulhall EM, Ye W, Smith AD, Liman ER (2018) An evolutionarily conserved gene family encodes proton-selective ion channels. Science 359:1047–1050. https://doi.org/10.1126/science.aao3264 pmid:29371428
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Ugawa S, Yamamoto T, Ueda T, Ishida Y, Inagaki A, Nishigaki M, Shimada S (2003) Amiloride-insensitive currents of the acid-sensing ion channel-2a (ASIC2a)/ASIC2b heteromeric sour-taste receptor channel. J Neurosci 23:3616–3622. https://doi.org/10.1523/JNEUROSCI.23-09-03616.2003 pmid:12736332
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Vandenbeuch A, Anderson CB, Parnes J, Enjyoji K, Robson SC, Finger TE, Kinnamon SC (2013) Role of the ectonucleotidase NTPDase2 in taste bud function. Proc Natl Acad Sci U S A 110:14789–14794. https://doi.org/10.1073/pnas.1309468110 pmid:23959882
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Vandenbeuch A, Larson ED, Anderson CB, Smith SA, Ford AP, Finger TE, Kinnamon SC (2015) Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in mice. J Physiol 593:1113–1125. https://doi.org/10.1113/jphysiol.2014.281014 pmid:25524179
    OpenUrlCrossRefPubMed
  46. ↵
    Wang H, Iguchi N, Rong Q, Zhou M, Ogunkorode M, Inoue M, Pribitkin EA, Bachmanov AA, Margolskee RF, Pfeifer K, Huang L (2009) Expression of the voltage-gated potassium channel KCNQ1 in mammalian taste bud cells and the effect of its null-mutation on taste preferences. J Comp Neurol 512:384–398. https://doi.org/10.1002/cne.21899 pmid:19006182
    OpenUrlCrossRefPubMed
  47. ↵
    Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AAM, Knollmann BC (2009) Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 15:380–383. https://doi.org/10.1038/nm.1942 pmid:19330009
    OpenUrlCrossRefPubMed
  48. ↵
    Ye W, Chang RB, Bushman JD, Tu YH, Mulhall EM, Wilson CE, Cooper AJ, Chick WS, Hill-Eubanks DC, Nelson MT, Kinnamon SC, Liman ER (2016) The K+ channel KIR2.1 functions in tandem with proton influx to mediate sour taste transduction. Proc Natl Acad Sci U S A 113:E229–E238.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Yoshida R, Ohkuri T, Jyotaki M, Yasuo T, Horio N, Yasumatsu K, Sanematsu K, Shigemura N, Yamamoto T, Margolskee RF, Ninomiya Y (2010) Endocannabinoids selectively enhance sweet taste. Proc Natl Acad Sci U S A 107:935–939. https://doi.org/10.1073/pnas.0912048107 pmid:20080779
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Zhang J, Jin H, Zhang W, Ding C, O’Keeffe S, Ye M, Zuker CS (2019) Sour sensing from the tongue to the brain. Cell 179:392–402.e15. https://doi.org/10.1016/j.cell.2019.08.031 pmid:31543264
    OpenUrlCrossRefPubMed

Synthesis

Reviewing Editor: Matthew Grubb, King’s College London

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Peihua Jiang. Note: If this manuscript was transferred from JNeurosci and a decision was made to accept the manuscript without peer review, a brief statement to this effect will instead be what is listed below.

Reviewer 1:

This manuscript describes that sour taste can be enhanced by a medicine via modulating the activity of Otop1. If it stands, this would advance our understanding of taste transduction.

Kawabata et al. performed a series of experiments to determine whether flecainide enhances the activity of Otop1, therefore, sour taste. The manuscript is easy to follow. Yet, their conclusion could be further strengthened by providing additional data. Below are my comments:

For Fig. 1, the pH value should be provided for each concentration of acids, including HCl (panel A), AA (panel B), CA (panel C), as Otop1 is a proton channel.

Data provided in Fig. 2 is less convincing, giving the huge variations in the preference ratio among mice in the control group (from strong preference to strong avoidance). The sample size with adequate power may matter here. There is a similar issue for the data in Fig .3C (big error bars).

For Fig. 4, the pH value should be provided for each concentration of acids. Based on my understanding, the authors used HBSS buffer supplemented with 5x test solutions to simulate cells expressing Otop1 or mock transfected cells. Checking pH values of these solutions would be important to interpret data. For comparison of strong and weak acids, solutions with the same pH value should be used.

For Fig.5, only one concentration of HCl was tested at presumably extremely low pH. In previous reports from the Liman lab, they showed that proton currents were evoked by rapidly lowering the pH and the Otop1 channel was closed rapidly after pH returned to 7.4. It makes more sense to include a few more data points (pH lowering to 6, 5.5, 5.0) to see if flecainide indeed affect the decay time.

Reviewer 2

This manuscript reports effects of the antiarrhythmic drug flecainide on taste behavior and physiology in mice. The authors show quite remarkably that a single IP injection of flecainide causes a dramatic change in licking behavior in response to HCl (it is aversive at a lower concentration), but not other sour or non-sour taste stimuli. Gustatory nerve recording showed a small increase in responses to HCl but not other sour or non-sour taste stimuli. These data, while interesting, are not consistent with a role for Otop1 in mediating the effect of flecainide on sour taste, as Otop1 has been shown to mediate responses to all acid stimuli tested in this manuscript (HCl, acetic acid and citric acid). Nonetheless, the authors test for a direct effect of flecainide on Otop1 expressed in HEK 293 cells. They report an increase in the magnitude of the voltage response as measured with voltage imaging in cells expressing Otop1 channels exposed to flecainide. However, this is not substantiated by patch clamp recording, where the authors observe no change in the magnitude of the responses, and instead observe a change in the kinetics of the currents. As described below, changes in voltage in imaging experiments are not reliable because there is no control for the resting voltage and if this is changed, as it very well could be by flecainide, the magnitude of the response evoked by the acid stimulus may change. Similarly, the kinetics of Otop1 currents is not likely to be an inherent feature of the channels, but instead may reflect pH buffering of the cells, which could be affected by flecainide. Thus, while the initial behavioral observation is interesting, and appears to be well substantiated, the evidence points, in my view, to a mechanism that is Otop1-independent. I believe if framed as such, this may nonetheless be a valuable contribution to the literature.

Major concerns.

1. I am concerned that the experimental results may be robust, but that the interpretation is incorrect. Importantly, the responses to citric acid and acetic acid, which are known to be mediated by Otop1 are unchanged after flecainide, both in behavioral experiments and gustatory nerve recording.

2. As described above, the voltage imaging data is not interpretable without a measurement of the resting voltage (to see if it has changed). In the absence of this experiment, I believe the results are misleading and should be omitted.

3. The patch clamp recording data is not convincing that flecainide acts on Otop1 directly. The decay of the currents has been attributed to acid loading of cells and therefore changes in current decay may be attributed to changes in handling of intracellular pH. I would also like to note that the recovery to baseline of the currents after washoff of the acid stimulus is not as quick as expected, calling into question any conclusions based on kinetics. Instead, I suggest the authors report there is no effect on the magnitude of the currents and omit discussion of the kinetics (unless they are willing to do the hard work of determining if this is due to changes in pH buffering).

4. To test whether flecainide works through Otop1 or even through taste cells, behavior should be measured f Otop1-/- mice or mice missing type III taste cells, which retain acid sensitivity and are available from several laboratories. Without doing these experiments, it would be premature to conclude that flecainide even works through the taste system.

In light of these concerns, and because the data appear to nonetheless be sound, I suggest the authors:

1. rewrite the title to indicate that Otop1 is not likely the target of flecainide. For example, they could use “The antiarrhythmic drug flecainide enhances aversion to HCl in mice”

2. Remove the claim “Unexpectedly, we found that flecainide interacts directly with the sour taste receptor, Otop1” (line 400). There is no evidence for a direct interaction/effect on Otop1.

3. Remove the claim on line 419: “Therefore, we suggest that the primary molecular target of flecainide in the taste system is Otop1 in sour-sensing taste cells”

4. Rewrite the last paragraph: “In conclusion, we found that flecainide enhances sour taste perception via an effect on Otop1 in mouse taste cells.” This is not true.

“Our research provides new insights into the molecular mechanisms of drug-induced taste disorders via Otop1, and may support that Otop1 as a sour taste receptor not only in mice, but also in humans.” Again, I do not believe there is any evidence in support of this statement.

“Our results also imply that the prescription of zinc, Otop1 antagonist, can be potentially used as therapeutic strategy to prevent the taste disfunction and dizziness induced by flecainide” There is no evidence for this in the manuscript. Effect of zinc on Otop1 were previously described.

“research to elucidate the interaction between flecainide and Otop1 at the atomic level

might facilitate the discovery of novel positive/negative allosteric modulators of Otop1.” This is misleading as there is no evidence for a direct effect of flecainide on Otop1.

5. Offer alternative interpretations: The drug may block K+ channels to enhance acid responses (either taste or trigeminal or both). The authors do this on line 453, but it is hidden in the discussion “Thus, flecainide may affect sour taste sensitivity in vivo by influencing the excitability of other molecules such as Kir2.1 as well as Otop1” Please add reference to role of Kir2.1 in sour cells.

Minor:

1. Line 416. Reference for “Recently, it was reported that knockout of Otop1 abolished

sour taste responses from sour-sensing taste receptor cells...” should include Teng et al. 2019.

2. Line 437: “The concentration ranges that induced a sour taste response in mouse CT nerve were very similar to those that activated mOtop1 in HEK293T cells.” First, this data is not novel and thus does not require discussion. Second, the responses in HEK cells are with a pH buffer and thus not comparable to gustatory nerve recording. Leave out.

3. The two-bottle taste preference is not convincing - I would like to see the primary data but it seems it is driven by two outliers in the untreated conditions. Also, the concentration of HCl is much lower that for the brief access, and at a concentration where in the brief access tests there is no difference between the treated and untreated conditions. I would suggest leaving this data out, given the wide variation in behavior in the control group on this assay.

4. In the gustatory nerve recordings, the changes in response to fle are very subtle. I appreciate that the authors show the actual traces, but in Fig 3A it appears there is no change in response to HCl. How was the data measured for Fig 3B?

5. Also please explain if there were any adverse effects of the flecainide

6. Please state why experiments were limited to male mice

7. For the patch clamp and imaging experiments the investigators should state the final pH of the acid solution (5 mM HCl). Presumably there was a buffer present so this will affect the final pH.

8. Why was Otop1 re-cloned from mouse kidney - is there evidence for Otop1 in mouse kidney? Did the sequence match that reported in the literature?

Back to top

In this issue

eneuro: 10 (9)
eNeuro
Vol. 10, Issue 9
September 2023
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Antiarrhythmic Drug Flecainide Enhances Aversion to HCl in Mice
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
The Antiarrhythmic Drug Flecainide Enhances Aversion to HCl in Mice
Yuko Kawabata, Shingo Takai, Keisuke Sanematsu, Ryusuke Yoshida, Fuminori Kawabata, Noriatsu Shigemura
eNeuro 11 September 2023, 10 (9) ENEURO.0048-23.2023; DOI: 10.1523/ENEURO.0048-23.2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
The Antiarrhythmic Drug Flecainide Enhances Aversion to HCl in Mice
Yuko Kawabata, Shingo Takai, Keisuke Sanematsu, Ryusuke Yoshida, Fuminori Kawabata, Noriatsu Shigemura
eNeuro 11 September 2023, 10 (9) ENEURO.0048-23.2023; DOI: 10.1523/ENEURO.0048-23.2023
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • antiarrhythmic drug
  • flecainide
  • taste
  • taste disorder

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • The Impact of Chemical Fixation on the Microanatomy of Mouse Organotypic Hippocampal Slices
  • Similarities and Distinctions between Cortical Neural Substrates That Underlie Generation of Malevolent Creative Ideas
Show more Research Article: New Research

Sensory and Motor Systems

  • Lateralization and time-course of cortical phonological representations during syllable production
  • Pupil size is sensitive to low-level stimulus features, independent of arousal-related modulation
Show more Sensory and Motor Systems

Subjects

  • Sensory and Motor Systems

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.